Your browser doesn't support javascript.
loading
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19.
Skalafouris, Christian; Samer, Caroline; Stirnemann, Jerome; Grosgurin, Olivier; Eggimann, François; Grauser, Damien; Reny, Jean-Luc; Bonnabry, Pascal; Guignard, Bertrand.
Afiliación
  • Skalafouris C; Pharmacy, Geneva University Hospitals, Geneva, Switzerland christian.skalafouris@hcuge.ch.
  • Samer C; Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), School of pharmaceutical sciences, University of Geneva, Geneva, Switzerland.
  • Stirnemann J; Clinical Pharmacology and Toxicology Division, Geneva University Hospitals, Geneva, Switzerland.
  • Grosgurin O; General Internal Medicine Division, Geneva University Hospitals, Geneve, Switzerland.
  • Eggimann F; General Internal Medicine Division, Geneva University Hospitals, Geneve, Switzerland.
  • Grauser D; Information Systems Department, Geneva University Hospitals, Geneva, Switzerland.
  • Reny JL; Information Systems Department, Geneva University Hospitals, Geneva, Switzerland.
  • Bonnabry P; General Internal Medicine Division, Geneva University Hospitals, Geneve, Switzerland.
  • Guignard B; Pharmacy, Geneva University Hospitals, Geneva, Switzerland.
Eur J Hosp Pharm ; 30(2): 113-116, 2023 03.
Article en En | MEDLINE | ID: mdl-33832918
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / COVID-19 Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Hosp Pharm Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / COVID-19 Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Hosp Pharm Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido